Simply-In-Time Educating (JiTT) lively studying pedagogy utilized by numerous disciplines, however its worth in skilled pharmacy curriculum has not been confirmed.
The purpose of our analysis is to implement and consider this system JiTT (PharmD) Physician of Pharmacy. The impetus in implementing JiTT into PharmD curriculum is to offer college students with the alternative to be taught out-of-classroom to advertise knowledge-based expertise.
The present research summarizes the implementation JiTT in 4 totally different circumstances: two iterations of the required programs “Built-in Microbiology and Virology” (Fall 2016 and Fall 2017) and “Built-in Immunology” (winter 2016-2017 and winter 2017-2018). JiTT together with knowledge-based questions in a a number of alternative format, built-in case research, and the scholars reply earlier than the precise lecture. After the conclusion of every course, college students are requested to give suggestions on JiTT utilization by the use of nameless surveys.
After the Fall of 2016 iterations of Microbiology & Virology course, college students discover an built-in case research to be useful (imply = 3.27 from a most of 4, SD = 0.62), and their total assist JiTT excessive (imply = 3.61 exit 4, SD = 0.50).
Omi/HtrA2 |
|||
MO15078 | Neuromics | 100 ug | EUR 459.6 |
HtrA2/Omi |
|||
E8ET1609-73 | EnoGene | 100ul | EUR 275 |
Description: Available in various conjugation types. |
HTRA2/Omi antibody |
|||
10R-1022 | Fitzgerald | 100 ul | EUR 320 |
|
|||
Description: Mouse monoclonal HtrA2/Omi antibody |
HtrA2/Omi Antibody |
|||
3497-100 | Biovision | each | EUR 405.6 |
HtrA2/Omi Antibody |
|||
3497R-100 | Biovision | each | EUR 379.2 |
HtrA2/Omi Antibody |
|||
3497R-30T | Biovision | each | EUR 175.2 |
HtrA2/Omi Antibody |
|||
48910 | SAB | 100ul | EUR 499 |
HtrA2/Omi Antibody |
|||
48910-100ul | SAB | 100ul | EUR 399.6 |
HtrA2/Omi Antibody |
|||
48910-50ul | SAB | 50ul | EUR 286.8 |
HtrA2 / Omi Antibody |
|||
F54030-0.1ML | NSJ Bioreagents | 0.1 ml | EUR 322.15 |
|
|||
Description: Serine protease that shows proteolytic activity against a non-specific substrate beta-casein. Promotes or induces cell death either by direct binding to and inhibition of BIRC proteins (also called inhibitor of apoptosis proteins, IAPs), leading to an increase in caspase activity, or by a BIRC inhibition-independent, caspase-independent and serine protease activity-dependent mechanism. Cleaves THAP5 and promotes its degradation during apoptosis. Isoform 2 seems to be proteolytically inactive. [UniProt] |
HtrA2 / Omi Antibody |
|||
F54031-0.1ML | NSJ Bioreagents | 0.1 ml | EUR 322.15 |
|
|||
Description: Serine protease that shows proteolytic activity against a non-specific substrate beta-casein. Promotes or induces cell death either by direct binding to and inhibition of BIRC proteins (also called inhibitor of apoptosis proteins, IAPs), leading to an increase in caspase activity, or by a BIRC inhibition-independent, caspase-independent and serine protease activity-dependent mechanism. Cleaves THAP5 and promotes its degradation during apoptosis. Isoform 2 seems to be proteolytically inactive. [UniProt] |
HTRA2 Antibody / Omi |
|||
RQ4736 | NSJ Bioreagents | 100ul | EUR 356.15 |
|
|||
Description: The HTRA2 gene encodes a serine protease. The protein has been localized in the endoplasmic reticulum and interacts with an alternatively spliced form of mitogen-activated protein kinase 14. The protein has also been localized to the mitochondria with release to the cytosol following apoptotic stimulus. The protein is thought to induce apoptosis by binding the apoptosis inhibitory protein baculoviral IAP repeat-containing 4. [RefSeq] |
HtrA2 Blocking Peptide |
|||
33R-10784 | Fitzgerald | 50 ug | EUR 145 |
|
|||
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of HtrA2 antibody, catalog no. 70R-11873 |
HTRA2 Blocking Peptide |
|||
DF7626-BP | Affbiotech | 1mg | EUR 234 |
Polyclonal HtrA2/Omi Antibody |
|||
APR07891G | Leading Biology | 0.1mg | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HtrA2/Omi . This antibody is tested and proven to work in the following applications: |
Polyclonal HtrA2/Omi Antibody |
|||
APR07892G | Leading Biology | 0.1mg | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HtrA2/Omi . This antibody is tested and proven to work in the following applications: |
HtrA2/Omi Conjugated Antibody |
|||
C48910 | SAB | 100ul | EUR 476.4 |
HtrA2/Omi protein (His tag) |
|||
80R-1010 | Fitzgerald | 100 ug | EUR 219 |
|
|||
Description: Purified recombinant Human HtrA2/Omi protein |
Recombinant Human HTRA2/Omi Protein |
|||
E40KMP1047 | EnoGene | 20ug | EUR 495 |
Recombinant Human Serine Protease HTRA2/HTRA2/Omi (C-6His) |
|||
AP75337 | SAB | 1mg | EUR 1599 |
|
AAP73995-100UG - HTRA2 Peptide - middle region |
|||
AAP73995-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP78962-100UG - HTRA2 Peptide - middle region |
|||
AAP78962-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
Polyclonal HTRA2 / OMI Antibody (C-Terminus) |
|||
APR07884G | Leading Biology | 0.05mg | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HTRA2 / OMI (C-Terminus). This antibody is tested and proven to work in the following applications: |
Polyclonal HTRA2 / OMI Antibody (C-Terminus) |
|||
APR07885G | Leading Biology | 0.05mg | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HTRA2 / OMI (C-Terminus). This antibody is tested and proven to work in the following applications: |
OMI Peptide |
|||
3319P | ProSci | 0.05 mg | EUR 197.7 |
Description: (CT) OMI peptide |
Recombinant Human HtrA2/Omi Protein (His Tag) |
|||
PKSH033408-10ug | Elabscience Biotech | 10ug | EUR 209 |
|
|||
Description: Human |
Recombinant Human HtrA2/Omi Protein (His Tag) |
|||
PKSH033408-50ug | Elabscience Biotech | 50ug | EUR 275 |
|
|||
Description: Human |
Recombinant Human HtrA2/Omi Protein (His Tag)(Active) |
|||
PKSH031504-100ug | Elabscience Biotech | 100ug | EUR 805 |
|
|||
Description: Human |
Htra2 (GFP-tagged) - Mouse HtrA serine peptidase 2 (Htra2) |
|||
MG207308 | Origene Technologies GmbH | 10 µg | Ask for price |
Mast Cell-Degranulating Peptide (MCD Peptide) / Peptide 401 |
|||
004-04 | PHOENIX PEPTIDE | 100 μg | EUR 140.4 |
Peptide T |
|||
057-01 | PHOENIX PEPTIDE | 5 mg | EUR 140.4 |
FGL Peptide |
|||
073-36 | PHOENIX PEPTIDE | 100 μg | EUR 214.92 |
APK peptide |
|||
076-81 | PHOENIX PEPTIDE | 200 μg | EUR 199.8 |
NEF peptide |
|||
076-83 | PHOENIX PEPTIDE | 500 μg | EUR 140.4 |
SHA peptide |
|||
076-84 | PHOENIX PEPTIDE | 500 μg | EUR 177.12 |
YSY peptide |
|||
076-86 | PHOENIX PEPTIDE | 100 μg | EUR 230.04 |
PSTAIR Peptide |
|||
070-61 | PHOENIX PEPTIDE | 500 μg | EUR 129.6 |
PGMtide Peptide |
|||
040-69 | PHOENIX PEPTIDE | 100 μg | EUR 316.44 |
Peptide E / 3200-Dalton Adrenal Enkephalin-Containing Peptide (Bovine) |
|||
024-57 | PHOENIX PEPTIDE | 200 μg | EUR 86.4 |
Adjuvant Peptide |
|||
070-05 | PHOENIX PEPTIDE | 500 μg | EUR 36.72 |
proSex peptide (20-55) |
|||
040-30 | PHOENIX PEPTIDE | 100 μg | EUR 355.32 |
proSex peptide (28-55) |
|||
040-31 | PHOENIX PEPTIDE | 100 μg | EUR 282.96 |
proSex peptide (40-55) |
|||
040-32 | PHOENIX PEPTIDE | 100 μg | EUR 214.92 |
Peptide-epsilon |
|||
058-22 | PHOENIX PEPTIDE | 500 μg | EUR 114.48 |
Delicious Peptide |
|||
070-21 | PHOENIX PEPTIDE | 5 mg | EUR 160.92 |
Peptide F-9 |
|||
038-06 | PHOENIX PEPTIDE | 200 μg | EUR 58.32 |
Sturgeon Peptide (137-158) |
|||
021-94 | PHOENIX PEPTIDE | 100 μg | EUR 177.12 |
NGR Peptide 1 |
|||
025-74 | PHOENIX PEPTIDE | 200 μg | EUR 184.68 |
Peptide Lv (Rat) |
|||
008-73 | PHOENIX PEPTIDE | 100 μg | EUR 469.8 |
Bombinin-Like Peptide 1 amide / prepro-Bombinin-Like Peptide (44-70) amide / prepro-Bombinin-Like Peptide (107-133) amide |
|||
007-60 | PHOENIX PEPTIDE | 100 μg | EUR 214.92 |
Bid BH3 peptide |
|||
025-87 | PHOENIX PEPTIDE | 1 mg | EUR 170.64 |
AF-16 Peptide |
|||
033-44 | PHOENIX PEPTIDE | 200 μg | EUR 214.92 |
Anorexigenic Peptide |
|||
070-10 | PHOENIX PEPTIDE | 5 mg | EUR 86.4 |
GnRH Associated Peptide (GAP) (1-13) / GnRH Precursor Peptide (14-26) (Human) |
|||
029-03 | PHOENIX PEPTIDE | 500 μg | EUR 114.48 |
GnRH Associated Peptide (GAP) (1-24) / GnRH Precursor Peptide (14-37) (Human) |
|||
029-04 | PHOENIX PEPTIDE | 100 μg | EUR 114.48 |
GnRH Associated Peptide (GAP) (1-53) / GnRH Precursor Peptide (14-66) (Human) |
|||
029-05 | PHOENIX PEPTIDE | 20 μg | EUR 267.84 |
GnRH Associated Peptide (GAP) (25-53) / GnRH Precursor Peptide (38-66) (Human) |
|||
029-06 | PHOENIX PEPTIDE | 100 μg | EUR 114.48 |
Peptide Lv (Human) |
|||
008-71 | PHOENIX PEPTIDE | 100 μg | EUR 405 |
Peptide Lv (Mouse) |
|||
008-72 | PHOENIX PEPTIDE | 100 μg | EUR 469.8 |
Human High temperature requirement protein A 2(HtrA2/Omi)ELISA Kit |
|||
QY-E01443 | Qayee Biotechnology | 96T | EUR 433.2 |
Peptide B (Bovine) |
|||
024-56 | PHOENIX PEPTIDE | 200 μg | EUR 81 |
Peptide F (Bovine) |
|||
024-58 | PHOENIX PEPTIDE | 200 μg | EUR 114.48 |
ExE peptide M3mP6 |
|||
064-33 | PHOENIX PEPTIDE | 200 μg | EUR 244.08 |
GnRH Associated Peptide (GAP) (1-13) / Gn-RH Precursor Peptide (14-26) (Rat) |
|||
029-08 | PHOENIX PEPTIDE | 200 μg | EUR 64.8 |
PLP Peptide (103-116) (Bovine) |
|||
070-14 | PHOENIX PEPTIDE | 5 mg | EUR 140.4 |
FMRF-Like Peptide |
|||
047-32 | PHOENIX PEPTIDE | 1 mg | EUR 27 |
Joining Peptide (Rat) |
|||
047-91 | PHOENIX PEPTIDE | 200 μg | EUR 160.92 |
Peptide T (4-8) |
|||
057-04 | PHOENIX PEPTIDE | 500 μg | EUR 64.8 |
Peptide T (5-8) |
|||
057-05 | PHOENIX PEPTIDE | 500 μg | EUR 64.8 |
Growth Hormone-Releasing Peptide-Related Peptide-1 (fGRP-RP-1) (Frog) |
|||
048-80 | PHOENIX PEPTIDE | 500 μg | EUR 177.12 |
Growth Hormone-Releasing Peptide-Related Peptide-2 (fGRP-RP-2) (Frog) |
|||
048-81 | PHOENIX PEPTIDE | 200 μg | EUR 214.92 |
Growth Hormone-Releasing Peptide-Related Peptide-3 (fGRP-RP-3) (Frog) |
|||
048-82 | PHOENIX PEPTIDE | 200 μg | EUR 214.92 |
Opioid Peptide Library |
|||
L-002 | PHOENIX PEPTIDE | 58 peptides | EUR 2691.36 |
Vasonatrin Peptide (VNP) |
|||
005-47 | PHOENIX PEPTIDE | 200 μg | EUR 214.92 |
[D-Ala1]-Peptide T |
|||
057-02 | PHOENIX PEPTIDE | 5 mg | EUR 282.96 |
Heparin Binding Peptide |
|||
025-47 | PHOENIX PEPTIDE | 500 μg | EUR 102.6 |
Gastrin Related Peptide |
|||
027-09 | PHOENIX PEPTIDE | 5 mg | EUR 73.44 |
PGMtide Control Peptide |
|||
040-70 | PHOENIX PEPTIDE | 100 μg | EUR 316.44 |
Growth Blocking Peptide |
|||
046-92 | PHOENIX PEPTIDE | 100 μg | EUR 255.96 |
Neuron Specific Peptide |
|||
047-55 | PHOENIX PEPTIDE | 200 μg | EUR 140.4 |
Obesity Peptide Library |
|||
L-003 | PHOENIX PEPTIDE | 160 peptides | EUR 7267.32 |
Peptide YY (PYY) (Human) |
|||
059-01 | PHOENIX PEPTIDE | 200 μg | EUR 119.88 |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) |
|||
064-01 | PHOENIX PEPTIDE | 200 μg | EUR 108 |
proSex peptide (28-55) - EIA Kit |
|||
EK-040-31 | PHOENIX PEPTIDE | 96 wells | EUR 603.72 |
Peptide F 1 (Lobster) |
|||
047-62 | PHOENIX PEPTIDE | 500 μg | EUR 73.44 |
Eledoisin Related Peptide |
|||
046-04 | PHOENIX PEPTIDE | 5 mg | EUR 58.32 |
Morphine Tolerance Peptide |
|||
050-13 | PHOENIX PEPTIDE | 1 mg | EUR 102.6 |
Phosphate Acceptor Peptide |
|||
058-24 | PHOENIX PEPTIDE | 500 μg | EUR 73.44 |
FGL Peptide - Cy3 Labeled |
|||
FC3-073-36 | PHOENIX PEPTIDE | 1 nmol | EUR 672.84 |
FGL Peptide - Cy5 Labeled |
|||
FC5-073-36 | PHOENIX PEPTIDE | 1 nmol | EUR 756 |
FGL Peptide - FAM Labeled |
|||
FG-073-36A | PHOENIX PEPTIDE | 1 nmol | EUR 405 |
Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia brasiliana) |
|||
047-39 | PHOENIX PEPTIDE | 200 μg | EUR 444.96 |
Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia brasiliana) |
|||
047-40 | PHOENIX PEPTIDE | 500 μg | EUR 214.92 |
Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia californica) |
|||
047-42 | PHOENIX PEPTIDE | 200 μg | EUR 444.96 |
Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia californica) |
|||
047-43 | PHOENIX PEPTIDE | 500 μg | EUR 214.92 |
For the three different packages which can be included on this research, the first dependent variable is the common worth of scholars from JiTT, rated on a five-point scale. Summing scores from the Fall 2017 iteration of the Built-in Microbiology & Virology course and the second instance of the Immunology course, college students are assessed JiTT very worthwhile (imply = 4.17 of a most of 5, SD = 0.77). scholar performances in JiTT primarily based packages in comparison with non-JiTT primarily based program.
Evaluation of evaluation knowledge on scholar efficiency on the knowledge-based questions present JiTT very useful for scholar studying and JiTT-based programs have a extra constant take a look at scores in comparison with non-JiTT primarily based program. The present outcomes are a promising first step in validating the usefulness JiTT in pharmaceutical packages and lay the groundwork for future research aiming for a direct comparability between the standard lecture model and JiTT pedagogy carried out into PharmD curriculum.
Summative evaluation blueprint idea to undergraduate medical college students in microbiology
Background: Evaluation drives studying. written appraisal from many universities don’t have a uniform and validation. subjectivity appraisal affect. The blueprint has been used as a method of content material validity.
Strategies: On this research, Maharashtra final 5-year College of Well being Sciences (MUHS) second 12 months MBBS papers in Microbiology evaluated for validity of its contents. Desired weightage to all of the subjects in microbiology given by the college’s Division of Microbiology. college papers are evaluated for degree of cognitive domains examined. Closed-ended suggestions from college taken and statistically evaluated.
Outcomes: The research revealed the overrepresentation and underrepresentation of many subjects in any respect the final 5 years the college paper with reference to microbiology. Cognitive dimensions examined in accordance query paper Bloom taxonomy revision was solely 8% of the Bloom degree 1, 20% of the extent 2, and eight% of the extent 3, whereas 64% of the questions had been ambiguous. College suggestions revealed a major impact (P <0.05) on blueprints in microbiology.
AAP77043-100UG - Tspan9 Peptide - C-terminal region | |||
AAP77043-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP78774-100UG - TSPAN9 Peptide - C-terminal region | |||
AAP78774-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
TSPAN14 Peptide | |||
43-172P | ProSci | 0.1 mg | EUR 405.6 |
Mast Cell-Degranulating Peptide (MCD Peptide) / Peptide 401 | |||
004-04 | PHOENIX PEPTIDE | 100 μg | EUR 140.4 |
TSPAN5 / NET-4 Peptide | |||
43-169P | ProSci | 0.1 mg | EUR 405.6 |
TSPAN8 Blocking Peptide | |||
DF3111-BP | Affbiotech | 1mg | EUR 234 |
TSPAN8 Blocking Peptide | |||
AF0362-BP | Affbiotech | 1mg | EUR 234 |
AAP50022-100UG - TSPAN10 Peptide | |||
AAP50022-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP46635-100UG - TSPAN32 Peptide | |||
AAP46635-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP46636-100UG - TSPAN32 Peptide | |||
AAP46636-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP46677-100UG - TSPAN31 Peptide | |||
AAP46677-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP46887-100UG - TSPAN12 Peptide | |||
AAP46887-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP46889-100UG - TSPAN15 Peptide | |||
AAP46889-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP45454-100UG - TSPAN6 Peptide | |||
AAP45454-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP46640-100UG - TSPAN5 Peptide | |||
AAP46640-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP46642-100UG - TSPAN3 Peptide | |||
AAP46642-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
Peptide T | |||
057-01 | PHOENIX PEPTIDE | 5 mg | EUR 140.4 |
FGL Peptide | |||
073-36 | PHOENIX PEPTIDE | 100 μg | EUR 214.92 |
APK peptide | |||
076-81 | PHOENIX PEPTIDE | 200 μg | EUR 199.8 |
NEF peptide | |||
076-83 | PHOENIX PEPTIDE | 500 μg | EUR 140.4 |
SHA peptide | |||
076-84 | PHOENIX PEPTIDE | 500 μg | EUR 177.12 |
YSY peptide | |||
076-86 | PHOENIX PEPTIDE | 100 μg | EUR 230.04 |
PSTAIR Peptide | |||
070-61 | PHOENIX PEPTIDE | 500 μg | EUR 129.6 |
PGMtide Peptide | |||
040-69 | PHOENIX PEPTIDE | 100 μg | EUR 316.44 |
Peptide E / 3200-Dalton Adrenal Enkephalin-Containing Peptide (Bovine) | |||
024-57 | PHOENIX PEPTIDE | 200 μg | EUR 86.4 |
Adjuvant Peptide | |||
070-05 | PHOENIX PEPTIDE | 500 μg | EUR 36.72 |
proSex peptide (20-55) | |||
040-30 | PHOENIX PEPTIDE | 100 μg | EUR 355.32 |
proSex peptide (28-55) | |||
040-31 | PHOENIX PEPTIDE | 100 μg | EUR 282.96 |
proSex peptide (40-55) | |||
040-32 | PHOENIX PEPTIDE | 100 μg | EUR 214.92 |
Peptide-epsilon | |||
058-22 | PHOENIX PEPTIDE | 500 μg | EUR 114.48 |
Delicious Peptide | |||
070-21 | PHOENIX PEPTIDE | 5 mg | EUR 160.92 |
Peptide F-9 | |||
038-06 | PHOENIX PEPTIDE | 200 μg | EUR 58.32 |
Sturgeon Peptide (137-158) | |||
021-94 | PHOENIX PEPTIDE | 100 μg | EUR 177.12 |
NGR Peptide 1 | |||
025-74 | PHOENIX PEPTIDE | 200 μg | EUR 184.68 |
Peptide Lv (Rat) | |||
008-73 | PHOENIX PEPTIDE | 100 μg | EUR 469.8 |
Bombinin-Like Peptide 1 amide / prepro-Bombinin-Like Peptide (44-70) amide / prepro-Bombinin-Like Peptide (107-133) amide | |||
007-60 | PHOENIX PEPTIDE | 100 μg | EUR 214.92 |
Bid BH3 peptide | |||
025-87 | PHOENIX PEPTIDE | 1 mg | EUR 170.64 |
AF-16 Peptide | |||
033-44 | PHOENIX PEPTIDE | 200 μg | EUR 214.92 |
Anorexigenic Peptide | |||
070-10 | PHOENIX PEPTIDE | 5 mg | EUR 86.4 |
GnRH Associated Peptide (GAP) (1-13) / GnRH Precursor Peptide (14-26) (Human) | |||
029-03 | PHOENIX PEPTIDE | 500 μg | EUR 114.48 |
GnRH Associated Peptide (GAP) (1-24) / GnRH Precursor Peptide (14-37) (Human) | |||
029-04 | PHOENIX PEPTIDE | 100 μg | EUR 114.48 |
GnRH Associated Peptide (GAP) (1-53) / GnRH Precursor Peptide (14-66) (Human) | |||
029-05 | PHOENIX PEPTIDE | 20 μg | EUR 267.84 |
GnRH Associated Peptide (GAP) (25-53) / GnRH Precursor Peptide (38-66) (Human) | |||
029-06 | PHOENIX PEPTIDE | 100 μg | EUR 114.48 |
Peptide Lv (Human) | |||
008-71 | PHOENIX PEPTIDE | 100 μg | EUR 405 |
Peptide Lv (Mouse) | |||
008-72 | PHOENIX PEPTIDE | 100 μg | EUR 469.8 |
AAP46888-100UG - TSPAN12 Peptide - middle region | |||
AAP46888-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP42969-100UG - TSPAN17 Peptide - middle region | |||
AAP42969-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP55781-100UG - TSPAN33 Peptide - middle region | |||
AAP55781-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP71899-100UG - TSPAN11 Peptide - middle region | |||
AAP71899-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP94110-100UG - TSPAN18 Peptide - middle region | |||
AAP94110-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
Peptide B (Bovine) | |||
024-56 | PHOENIX PEPTIDE | 200 μg | EUR 81 |
Peptide F (Bovine) | |||
024-58 | PHOENIX PEPTIDE | 200 μg | EUR 114.48 |
ExE peptide M3mP6 | |||
064-33 | PHOENIX PEPTIDE | 200 μg | EUR 244.08 |
GnRH Associated Peptide (GAP) (1-13) / Gn-RH Precursor Peptide (14-26) (Rat) | |||
029-08 | PHOENIX PEPTIDE | 200 μg | EUR 64.8 |
PLP Peptide (103-116) (Bovine) | |||
070-14 | PHOENIX PEPTIDE | 5 mg | EUR 140.4 |
FMRF-Like Peptide | |||
047-32 | PHOENIX PEPTIDE | 1 mg | EUR 27 |
Joining Peptide (Rat) | |||
047-91 | PHOENIX PEPTIDE | 200 μg | EUR 160.92 |
Peptide T (4-8) | |||
057-04 | PHOENIX PEPTIDE | 500 μg | EUR 64.8 |
Peptide T (5-8) | |||
057-05 | PHOENIX PEPTIDE | 500 μg | EUR 64.8 |
AAP44756-100UG - TSPAN4 Peptide - middle region | |||
AAP44756-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP46477-100UG - TSPAN8 Peptide - middle region | |||
AAP46477-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP46643-100UG - TSPAN2 Peptide - middle region | |||
AAP46643-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP43528-100UG - TSPAN1 Peptide - middle region | |||
AAP43528-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
Growth Hormone-Releasing Peptide-Related Peptide-1 (fGRP-RP-1) (Frog) | |||
048-80 | PHOENIX PEPTIDE | 500 μg | EUR 177.12 |
Growth Hormone-Releasing Peptide-Related Peptide-2 (fGRP-RP-2) (Frog) | |||
048-81 | PHOENIX PEPTIDE | 200 μg | EUR 214.92 |
Growth Hormone-Releasing Peptide-Related Peptide-3 (fGRP-RP-3) (Frog) | |||
048-82 | PHOENIX PEPTIDE | 200 μg | EUR 214.92 |
Opioid Peptide Library | |||
L-002 | PHOENIX PEPTIDE | 58 peptides | EUR 2691.36 |
Vasonatrin Peptide (VNP) | |||
005-47 | PHOENIX PEPTIDE | 200 μg | EUR 214.92 |
[D-Ala1]-Peptide T | |||
057-02 | PHOENIX PEPTIDE | 5 mg | EUR 282.96 |
Heparin Binding Peptide | |||
025-47 | PHOENIX PEPTIDE | 500 μg | EUR 102.6 |
Gastrin Related Peptide | |||
027-09 | PHOENIX PEPTIDE | 5 mg | EUR 73.44 |
PGMtide Control Peptide | |||
040-70 | PHOENIX PEPTIDE | 100 μg | EUR 316.44 |
Growth Blocking Peptide | |||
046-92 | PHOENIX PEPTIDE | 100 μg | EUR 255.96 |
Neuron Specific Peptide | |||
047-55 | PHOENIX PEPTIDE | 200 μg | EUR 140.4 |
Obesity Peptide Library | |||
L-003 | PHOENIX PEPTIDE | 160 peptides | EUR 7267.32 |
Peptide YY (PYY) (Human) | |||
059-01 | PHOENIX PEPTIDE | 200 μg | EUR 119.88 |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) | |||
064-01 | PHOENIX PEPTIDE | 200 μg | EUR 108 |
proSex peptide (28-55) - EIA Kit | |||
EK-040-31 | PHOENIX PEPTIDE | 96 wells | EUR 603.72 |
Peptide F 1 (Lobster) | |||
047-62 | PHOENIX PEPTIDE | 500 μg | EUR 73.44 |
Eledoisin Related Peptide | |||
046-04 | PHOENIX PEPTIDE | 5 mg | EUR 58.32 |
AAP42968-100UG - TSPAN17 Peptide - N-terminal region | |||
AAP42968-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
AAP55782-100UG - Tspan33 Peptide - C-terminal region | |||
AAP55782-100UG | Aviva Systems Biology | 100ug | EUR 99 |
|
Morphine Tolerance Peptide | |||
050-13 | PHOENIX PEPTIDE | 1 mg | EUR 102.6 |
Phosphate Acceptor Peptide | |||
058-24 | PHOENIX PEPTIDE | 500 μg | EUR 73.44 |
FGL Peptide - Cy3 Labeled | |||
FC3-073-36 | PHOENIX PEPTIDE | 1 nmol | EUR 672.84 |
FGL Peptide - Cy5 Labeled | |||
FC5-073-36 | PHOENIX PEPTIDE | 1 nmol | EUR 756 |
FGL Peptide - FAM Labeled | |||
FG-073-36A | PHOENIX PEPTIDE | 1 nmol | EUR 405 |
Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia brasiliana) | |||
047-39 | PHOENIX PEPTIDE | 200 μg | EUR 444.96 |
Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia brasiliana) | |||
047-40 | PHOENIX PEPTIDE | 500 μg | EUR 214.92 |
Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia californica) | |||
047-42 | PHOENIX PEPTIDE | 200 μg | EUR 444.96 |
Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia californica) | |||
047-43 | PHOENIX PEPTIDE | 500 μg | EUR 214.92 |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) | |||
064-07 | PHOENIX PEPTIDE | 200 μg | EUR 114.48 |
Pedal Peptide (Pep) (Aplysia) | |||
047-61 | PHOENIX PEPTIDE | 500 μg | EUR 177.12 |
Conclusions: Evaluation have to be tailored to the training aims, and blueprints enhance content material validity.